{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:01:11Z","timestamp":1760061671770},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:00:00Z","timestamp":1361232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s12253-013-9608-2","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:28:45Z","timestamp":1361233725000},"page":"501-508","source":"Crossref","is-referenced-by-count":8,"title":["Bevacizumab Treatment Before Resection of Colorectal Liver Metastases: Safety, Recovery of Liver Function, Pathologic Assesment"],"prefix":"10.1007","volume":"19","author":[{"given":"K.","family":"Dede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Mersich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Beszny\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zar\u00e1nd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zs.","family":"Baranyai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Landherr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Jakab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bursics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,19]]},"reference":[{"key":"9608_CR1","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.sla.0000145964.08365.01","volume":"240","author":"R Adam","year":"2004","unstructured":"Adam R, Delvart V, Pascal G et al (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240:644\u2013657","journal-title":"Ann Surg"},{"issue":"32","key":"9608_CR2","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1200\/JCO.2008.17.7857","volume":"26","author":"B Kesmodel","year":"2008","unstructured":"Kesmodel B, Ellis L et al (2008) Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol 26(32):5224\u20135260","journal-title":"J Clin Oncol"},{"issue":"3","key":"9608_CR3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/bjs.7368","volume":"98","author":"DA Wicherts","year":"2011","unstructured":"Wicherts DA, de Haas RJ, Adam R et al (2011) Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases. Br J Surg 98(3):399\u2013407","journal-title":"Br J Surg"},{"issue":"1","key":"9608_CR4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(09)70330-4","volume":"11","author":"G Folprecht","year":"2010","unstructured":"Folprecht G, Gruenberger T, Bechstein WO et al (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 11(1):38\u201347","journal-title":"Lancet Oncol"},{"issue":"11","key":"9608_CR5","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/annonc\/mdp233","volume":"20","author":"E Cutsem Van","year":"2009","unstructured":"Van Cutsem E, Rivera F, Berry S et al (2009) Safety and efficacy of firstline bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol 20(11):1842\u20131847","journal-title":"Ann Oncol"},{"issue":"1","key":"9608_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1245\/s10434-008-0190-x","volume":"16","author":"CR Scoggins","year":"2009","unstructured":"Scoggins CR, Campbell ML, Landry CS et al (2009) Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol 16(1):35\u201341","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"9608_CR7","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","volume":"24","author":"JN Vauthey","year":"2006","unstructured":"Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24(13):2065\u20132072","journal-title":"J Clin Oncol"},{"issue":"12","key":"9608_CR8","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/cncr.23099","volume":"110","author":"D Ribero","year":"2007","unstructured":"Ribero D, Wang H, Donadon M et al (2007) Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 110(12):2761\u20132767","journal-title":"Cancer"},{"issue":"5","key":"9608_CR9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejso.2008.12.013","volume":"35","author":"M Klinger","year":"2009","unstructured":"Klinger M, Eipeldauer S, Hacker S et al (2009) Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX\/FOLFOX therapy of colorectal cancer liver metastases. Eur J Surg Oncol 35(5):515\u2013520","journal-title":"Eur J Surg Oncol"},{"key":"9608_CR10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1245\/s10434-006-9074-0","volume":"14","author":"M D\u2019Angelica","year":"2007","unstructured":"D\u2019Angelica M, Kornprat P, Gonen M et al (2007) Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched casecontrol study. An Surg Oncol 14:759\u2013765","journal-title":"An Surg Oncol"},{"issue":"22","key":"9608_CR11","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1200\/JCO.2005.23.754","volume":"23","author":"LM Ellis","year":"2005","unstructured":"Ellis LM, Curley SA et al (2005) Surgical resection after downsizing of colorectal liver metastasis in the era of Bevacizumab. J Clin Oncol 23(22):4853\u20134855","journal-title":"J Clin Oncol"},{"key":"9608_CR12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jamcollsurg.2007.06.290","volume":"206","author":"SK Reddy","year":"2008","unstructured":"Reddy SK, Morse MA, Hurwitz HI et al (2008) Addition of bevacizumab to irinotecan and oxaliplatin based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases. J Am Coll Surg 206:96\u2013106","journal-title":"J Am Coll Surg"},{"issue":"1","key":"9608_CR13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00268-009-0251-8","volume":"34","author":"M Mahfud","year":"2010","unstructured":"Mahfud M, Breitenstein S, El-Badry AM et al (2010) Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study. World J Surg 34(1):92\u2013100","journal-title":"World J Surg"},{"key":"9608_CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment is solid tumors. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"9608_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","journal-title":"Ann Surg"},{"issue":"33","key":"9608_CR16","first-page":"5344","volume":"25","author":"G Dan","year":"2008","unstructured":"Dan G, Blazer III, Kishi Y et al (2008) Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 25(33):5344\u20135351","journal-title":"J Clin Oncol"},{"issue":"4","key":"9608_CR17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3816\/CCC.2010.n.031","volume":"9","author":"B Nordlinger","year":"2010","unstructured":"Nordlinger B, Vauthey J-N, Poston G et al (2010) The timing of chemotherapy and surgery for the treatment of colorectal liver metastases. Clin Colorectal Cancer 9(4):212\u2013218","journal-title":"Clin Colorectal Cancer"},{"key":"9608_CR18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejso.2011.10.013","volume":"38","author":"L Spelt","year":"2012","unstructured":"Spelt L, Andersson B, Nilsson J, Andersson R (2012) Prognostic models for outcome following liver resection for colorectal cancer metastases: a systematic review. EJSO 38:16\u201324","journal-title":"EJSO"},{"issue":"11","key":"9608_CR19","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.2007.13.7679","volume":"26","author":"B Gruenberger","year":"2008","unstructured":"Gruenberger B, Tamandl D, Schueller J et al (2008) Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 26(11):1830\u20131835","journal-title":"J Clin Oncol"},{"issue":"9617","key":"9608_CR20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","volume":"371","author":"B Nordlinger","year":"2008","unstructured":"Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapywith FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomisedcontrolled trial. Lancet 371(9617):1007\u20131016","journal-title":"Lancet"},{"issue":"2","key":"9608_CR21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1245\/s10434-009-0781-1","volume":"17","author":"TC Chua","year":"2010","unstructured":"Chua TC, Saxena A, Liauw A et al (2010) Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol 17(2):492\u2013501","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"9608_CR22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdn735","volume":"20","author":"B Nordlinger","year":"2009","unstructured":"Nordlinger B, Van Cutsem E, Gruenberger T, European Colorectal Metastases Treatment Group; Sixth International Colorectal Liver Metastases Workshop et al (2009) Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 20(6):985\u2013992","journal-title":"Ann Oncol"},{"key":"9608_CR23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/SLA.0b013e3182356236","volume":"255","author":"K Lehmann","year":"2012","unstructured":"Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA (2012) Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg 255:237\u2013247","journal-title":"Ann Surg"},{"key":"9608_CR24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jso.20301","volume":"91","author":"FA Scappaticci","year":"2005","unstructured":"Scappaticci FA, Fehrenbacher L, Cartwright T et al (2005) Surgical woundhealing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol 91:173\u2013180","journal-title":"J Surg Oncol"},{"issue":"1","key":"9608_CR25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/SLA.0b013e3181deb67f","volume":"252","author":"D Tamandl","year":"2010","unstructured":"Tamandl D, Gruenberger B, Klinger M et al (2010) Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study. Ann Surg 252(1):124\u2013130","journal-title":"Ann Surg"},{"issue":"11","key":"9608_CR26","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1245\/s10434-010-1166-1","volume":"17","author":"Y Kishi","year":"2010","unstructured":"Kishi Y, Zorzi D, Contreras CM et al (2010) Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 17(11):2870\u20132876","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"9608_CR27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/JCO.2001.19.3.843","volume":"19","author":"MS Gordon","year":"2001","unstructured":"Gordon MS, Margolin K, Talpaz M et al (2001) Phase I safety and pharmacokineticstudy of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol 19(3):843\u2013850","journal-title":"J Clin Oncol"},{"issue":"21","key":"9608_CR28","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1001\/jama.2009.1755","volume":"302","author":"YS Chun","year":"2009","unstructured":"Chun YS, Vauthey JN, Boonsirikamchai P et al (2009) Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal livermetastases. JAMA 302(21):2338\u20132344","journal-title":"JAMA"},{"key":"9608_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/annonc\/mdl386","volume":"18","author":"L Rubbia-Brandt","year":"2007","unstructured":"Rubbia-Brandt L, Giostra E, Brezault C et al (2007) Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by liver surgery. Ann Oncol 18:299\u2013304","journal-title":"Ann Oncol"},{"key":"9608_CR30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/PAS.0b013e3181eb2f7b","volume":"34","author":"MM Dipen","year":"2010","unstructured":"Dipen MM, Kopetz S, Boonsirikamchai P et al (2010) Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol 34:1287\u20131294","journal-title":"Am J Surg Pathol"},{"key":"9608_CR31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/PAS.0b013e31824057e7","volume":"36","author":"HH Li Chang","year":"2012","unstructured":"Li Chang HH, Leeper WR, Chan G, Quan D, Driman DK (2012) Infarct-like necrosis. A distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy. Am J Surg Pathol 36:570\u2013576","journal-title":"Am J Surg Pathol"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9608-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-013-9608-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9608-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:39:22Z","timestamp":1559443162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-013-9608-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,19]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["9608"],"URL":"https:\/\/doi.org\/10.1007\/s12253-013-9608-2","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,19]]}}}